Similar Items: Real‐World Treatment and Outcomes in Resectable Early‐Stage Non‐Small Cell Cancer: THASSOS‐INTL Australia Cohort
- Six‐month real‐world amyloid PET outcomes after lecanemab: Greater amyloid reduction at the MCI stage than in dementia
- Outcome Measures for Dementia in the Advanced Stage and at the End of Life
- Design and baseline findings of the NEODEM prospective cohort on early‐onset neurodegenerative dementia
- From clinical trial to clinical experience: Lecanemab therapy in a real‐world case series
- Real‐world use of lecanemab: patient pathway findings from a US multicenter study
- Real‐world pharmacovigilance for anti‐Aβ therapies using a large language model